tiprankstipranks
Advertisement
Advertisement

SRZN Stock Latest News

Surrozen Earns Buy Rating on Advancing Retinal Pipeline, Strong Cash Runway, and Large wAMD/DME Market Opportunity
RatingsSurrozen Earns Buy Rating on Advancing Retinal Pipeline, Strong Cash Runway, and Large wAMD/DME Market Opportunity
31m ago
SRZN
Surrozen reports Q1 EPS ($11.65) vs. ($7.43) last year
PremiumThe Fly
Surrozen reports Q1 EPS ($11.65) vs. ($7.43) last year
5h ago
SRZN
Surrozen management to meet with Cantor
PremiumThe Fly
Surrozen management to meet with Cantor
7d ago
SRZN
Surrozen: Buy Rating Reiterated as Analyst Highlights Wnt-Targeted Ophthalmology Strategy and Maintains $37 Price Target
PremiumRatings
Surrozen: Buy Rating Reiterated as Analyst Highlights Wnt-Targeted Ophthalmology Strategy and Maintains $37 Price Target
9d ago
SRZN
Surrozen initiated with a Buy at TD Cowen
PremiumThe Fly
Surrozen initiated with a Buy at TD Cowen
16d ago
SRZN
Surrozen price target raised to $36 from $32 at H.C. Wainwright
PremiumThe FlySurrozen price target raised to $36 from $32 at H.C. Wainwright
1M ago
SRZN
Surrozen files $200M mixed securities shelf
Premium
The Fly
Surrozen files $200M mixed securities shelf
1M ago
SRZN
Surrozen, Inc. (SRZN) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Surrozen, Inc. (SRZN) Q4 Earnings Cheat Sheet
2M ago
SRZN
Surrozen initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Surrozen initiated with an Overweight at Cantor Fitzgerald
3M ago
SRZN
Surrozen announces routine board resignation with no disputes
PremiumCompany Announcements
Surrozen announces routine board resignation with no disputes
3M ago
8K
SRZN
Surrozen’s Innovative Wnt-Targeted Therapies Poised to Disrupt $15 Billion Anti-VEGF Market: A Compelling Buy Recommendation
PremiumRatings
Surrozen’s Innovative Wnt-Targeted Therapies Poised to Disrupt $15 Billion Anti-VEGF Market: A Compelling Buy Recommendation
6M ago
SRZN
Surrozen initiated with an Outperform at LifeSci Capital
PremiumThe Fly
Surrozen initiated with an Outperform at LifeSci Capital
6M ago
SRZN
Surrozen, Inc. Reports Significant Q3 2025 Loss
PremiumCompany AnnouncementsSurrozen, Inc. Reports Significant Q3 2025 Loss
6M ago
SRZN
Surrozen’s Innovative Wnt Pathway Advancements in Retinal Disease Treatment Earns Buy Rating
Premium
Ratings
Surrozen’s Innovative Wnt Pathway Advancements in Retinal Disease Treatment Earns Buy Rating
6M ago
SRZN
Surrozen Appoints Andrew Maleki as New CFO
Premium
Company Announcements
Surrozen Appoints Andrew Maleki as New CFO
6M ago
8K
SRZN
Surrozen names Andrew Maleki as CFO
PremiumThe Fly
Surrozen names Andrew Maleki as CFO
6M ago
SRZN
Surrozen’s Collaboration Agreement with TCGFB Terminated
PremiumCompany Announcements
Surrozen’s Collaboration Agreement with TCGFB Terminated
7M ago
8K
SRZN
Surrozen Signs $50M Sales Agreement with TD Securities
PremiumCompany Announcements
Surrozen Signs $50M Sales Agreement with TD Securities
8M ago
8K
SRZN
Surrozen’s Innovative Wnt Pathway Approach Garners Buy Rating Amid Promising Preclinical Data
PremiumRatings
Surrozen’s Innovative Wnt Pathway Approach Garners Buy Rating Amid Promising Preclinical Data
9M ago
SRZN
Surrozen’s Q2 2025: Progress in Eye Disease Therapies
PremiumCompany AnnouncementsSurrozen’s Q2 2025: Progress in Eye Disease Therapies
9M ago
SRZN
Surrozen files $150M mixed securities shelf
Premium
The Fly
Surrozen files $150M mixed securities shelf
12M ago
SRZN
Surrozen Holds Successful 2025 Annual Stockholders Meeting
Premium
Company Announcements
Surrozen Holds Successful 2025 Annual Stockholders Meeting
12M ago
8K
SRZN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >